PHK
MXCT icon

Point72 Hong Kong’s MaxCyte MXCT Stock Holding History

Point72 Hong Kong’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,904
Closed -$121K – 2209
2021
Q3 		$121K Buy
+9,904
New +$149K ﹤0.01% 1295

Other funds holding MXCT

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RGI
River Global Investors London, United Kingdom $515M AUM 24.86% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Point72 Hong Kong's MXCT Position: Q4 2021 in Review

Point72 Hong Kong sold out of MaxCyte (MXCT) in Q4 2021, closing a stake of 9,904 shares — an estimated $121K sold.

Point72 Hong Kong first reported a position in MXCT in Q3 2021 and held it in 1 quarter. The position peaked at $121K in Q3 2021. 103 funds tracked by Wall St. Rank hold MXCT as of Q4 2021.

  • Point72 Hong Kong reported no remaining MaxCyte position as of Q4 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 9,904 MaxCyte shares in Q4 2021, an estimated $121K.
  • Point72 Hong Kong first reported a position in MaxCyte in Q3 2021 and held it in 1 quarter.
  • Point72 Hong Kong's MaxCyte position peaked at $121K in Q3 2021.
  • 103 funds tracked by Wall St. Rank held MaxCyte as of Q4 2021.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.